Yu H. Yao

12 Wulumuqi Middle Road
Shanghai, 200040, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 92 publications

A Nomogram for Predicting 28-Day Mortality in Critically Ill Patients With Prostate Cancer: A Retrospective Cohort Study Based on the MIMIC-IV Database.

A Nomogram for Predicting 28-Day Mortality in Critically Ill Patients With Prostate Cancer: A Retrospective Cohort Study Based on the MIMIC-IV Database.

Journal: Archivos espanoles de urologia

Published: June 10, 2026

Patentability of antibodies in the artificial intelligence era.

Patentability of antibodies in the artificial intelligence era.

Journal: Trends in biotechnology

Published: March 05, 2026

Convection-Enhanced Delivery of Tumor-Infiltrating Lymphocytes Enhances Intratumoral Distribution and Therapeutic Efficacy in an Orthotopic Rat Glioma Model.

Convection-Enhanced Delivery of Tumor-Infiltrating Lymphocytes Enhances Intratumoral Distribution and Therapeutic Efficacy in an Orthotopic Rat Glioma Model.

Journal: Biomedicines

Published: February 25, 2026

Governing E-cigarettes in China: regulatory challenges and strategies for adolescent protection in the post-flavor ban era.

Governing E-cigarettes in China: regulatory challenges and strategies for adolescent protection in the post-flavor ban era.

Journal: Frontiers in public health

Published: February 18, 2026

BTKi orelabrutinib improved the outcome of newly-diagnosed PCNS-LBCL by alleviating MyD88L265P-induced PIM1 stability.

BTKi orelabrutinib improved the outcome of newly-diagnosed PCNS-LBCL by alleviating MyD88L265P-induced PIM1 stability.

Journal: Journal of hematology & oncology

Published: January 31, 2026

Vebreltinib for Previously Treated Astrocytoma, IDH-Mutant, Grade 4, and Glioblastoma, IDH Wild-Type with PTPRZ1-MET Fusion Gene: A Multicenter, Phase III Randomized, Open-Label Trial.

Vebreltinib for Previously Treated Astrocytoma, IDH-Mutant, Grade 4, and Glioblastoma, IDH Wild-Type with PTPRZ1-MET Fusion Gene: A Multicenter, Phase III Randomized, Open-Label Trial.

Journal: Cancer communications (London, England)

Published: November 22, 2025

Updated clinical practice guidelines for the management of adult diffuse gliomas.

Updated clinical practice guidelines for the management of adult diffuse gliomas.

Journal: Cancer letters

Published: September 03, 2025

A comprehensive benchmarking for spatially resolved transcriptomics clustering methods across variable technologies, organs, and replicates.

A comprehensive benchmarking for spatially resolved transcriptomics clustering methods across variable technologies, organs, and replicates.

Journal: iMeta

Published: July 09, 2025

Contrasting selective signatures of gene expression plasticity in response to antifungal clotrimazole and common environmental stresses in yeast.

Contrasting selective signatures of gene expression plasticity in response to antifungal clotrimazole and common environmental stresses in yeast.

Journal: Nature communications

Published: March 20, 2025

Computer-assisted rehabilitation system in the use of motor function recovery: A protocol for scoping review.

Computer-assisted rehabilitation system in the use of motor function recovery: A protocol for scoping review.

Journal: PloS one

Published: March 08, 2025

Regulating addictive algorithms and designs: protecting older adults from digital exploitation beyond a youth-centric approach.

Regulating addictive algorithms and designs: protecting older adults from digital exploitation beyond a youth-centric approach.

Journal: Frontiers in psychology

Published: February 20, 2025

Cisplatin and Alternating Temozolomide in Recurrent High-Grade Gliomas: Efficacy and the Role of Tumor-Infiltrating Lymphocytes in a Phase II Clinical Trial.

Cisplatin and Alternating Temozolomide in Recurrent High-Grade Gliomas: Efficacy and the Role of Tumor-Infiltrating Lymphocytes in a Phase II Clinical Trial.

Journal: Clinical Medicine Insights. Oncology

Published: February 07, 2025

Showing 1-12 of 92

Last Updated: 09/26/2026